In a relatively quiet month for price rises among typical generics in the UK, four presentations of the same molecule – epilepsy drug lamotrigine – topped our table of Biggest Risers in October, based on the latest figures from market researcher WaveData which monitors trade prices to UK independent pharmacists.
“All four strengths of this epilepsy medication feature in our Biggest Risers table, with the lowest strength taking the top spot,” WaveData observed
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?